Peroxisome-proliferator-activated receptors γ and β/δ mediate vascular endothelial growth factor production in colorectal tumor cells
- 11 March 2010
- journal article
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 137 (1) , 29-39
Abstract
Peroxisome-proliferator-activated receptors (PPARs) are nuclear receptors for fatty acids and their derivatives. PPAR subtypes PPARγ and PPARβ/δ are suspected to modulate cancer development in the colon, but their exact role is still discussed controversially. The present study investigated the impact of PPARγ and PPARβ/δ on vascular endothelial growth factor (VEGF) and cyclooxygenase 2 (COX-2) expressions induced by synthetic and physiological agonists in the colorectal tumor cell lines SW480 and HT29 using reporter gene assays, qRT-PCR and ELISA. Activation of both PPARγ and PPARβ/δ induced expression of VEGF mRNA and protein in a PPAR-dependent way. The PPARγ agonists ciglitazone and PGJ2 were the most effective inducers with up to ninefold and threefold increases in VEGF mRNA in SW480 and HT29 cultures, respectively. VEGF secretion was doubled in both cell lines. The PPARβ/δ agonists GW501516 and PGI2 caused stimulations of only 1.5-fold in both cell lines. In addition, all PPAR agonists induced COX-2 mRNA and secretion of the COX-2 product PGE2 in HT29 cells. However, this effect was not blocked by knock-down of PPAR expression nor was it essential for VEGF expression as shown by the lack of effect of the COX-2 inhibitor SC236. In summary, our results identify both PPARγ and PPARβ/δ as an alternative COX-independent mechanism of VEGF induction in colorectal tumor cells.Keywords
This publication has 51 references indexed in Scilit:
- Role of peroxisome-proliferator-activated receptor β/δ (PPARβ/δ) in gastrointestinal tract function and diseaseClinical Science, 2008
- Peroxisome Proliferator‐Activated Receptors and Progression of Colorectal CancerPPAR Research, 2008
- Crosstalk between peroxisome proliferator-activated receptor δ and VEGF stimulates cancer progressionProceedings of the National Academy of Sciences, 2006
- Expression of PPARδ in multistage carcinogenesis of the colorectum: implications of malignant cancer morphologyBritish Journal of Cancer, 2006
- Ligand Activation of Peroxisome Proliferator–Activated Receptor β Inhibits Colon CarcinogenesisCancer Research, 2006
- PPARδ activation induces COX-2 gene expression and cell proliferation in human hepatocellular carcinoma cellsBiochemical and Biophysical Research Communications, 2003
- The biology of VEGF and its receptorsNature Medicine, 2003
- Peroxisome proliferator-activated receptor γ ligands suppress colon carcinogenesis induced by azoxymethane in miceGastroenterology, 2003
- Differential Regulation of Vascular Endothelial Growth Factor Expression by Peroxisome Proliferator-activated Receptors in Bladder Cancer CellsJournal of Biological Chemistry, 2002
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996